Novel F8 and F9 gene variants from the PedNet hemophilia registry classified according to ACMG/AMP guidelines

Nadine G Andersson, Veerle Labarque, Anna Letelier, Maria Elisa Mancuso, Martina Bührlen, Kathelijn Fischer, Mutlu Kartal-Kaess, Minna Koskenvuo, Torben Mikkelsen, Rolf Ljung, PedNet study group, Nadine G Andersson, Veerle Labarque, Anna Letelier, Maria Elisa Mancuso, Martina Bührlen, Kathelijn Fischer, Mutlu Kartal-Kaess, Minna Koskenvuo, Torben Mikkelsen, Rolf Ljung, PedNet study group

Abstract

In hemophilia A and B, analysis of the F8 and F9 gene variants enables carrier and prenatal diagnosis and prediction of risk for the development of inhibitors. The PedNet Registry collects clinical, genetic, and phenotypic data prospectively on more than 2000 children with hemophilia. The genetic reports of F8/F9 gene variants were classified uniformly to Human Genome Variation Society nomenclature and reevaluated using international population- and disease-specific databases, literature survey and, where applicable, computational predictive programs. We report 88 novel variants in the F8 and F9 genes, 80 fulfilling criteria for Class 5 (pathogenic), six for Class 4 (likely pathogenic) and two fulfilling criteria for Class 3 (variant of unknown significance) of the American College of Medical Genetics and Genomics/Association for Molecular Pathologyguidelines together with information on the respective phenotype and inhibitor formation. The study highlights the need to reevaluate and update earlier genetic reports in hemophilia both locally but also in variant databases in light of changed nomenclature and new guidelines.

Keywords: F8 gene; F9 gene; Factor IX; Factor VIII; hemophilia; variant database.

Conflict of interest statement

The authors declare that there are no conflict of interests.

© 2020 The Authors. Human Mutation published by Wiley Periodicals LLC.

References

    1. Amendola, L. M. , Jarvik, G. P. , Leo, M. C. , McLaughlin, H. M. , Akkari, Y. , Amaral, M. D. , & Rehm, H. L. (2016). Performance of ACMG‐AMP Variant‐Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. American Journal of Human Genetics, 98(6), 1067–1076. 10.1016/j.ajhg.2016.03.024
    1. Andersson, N. G. , Auerswald, G. , Barnes, C. , Carcao, M. , Dunn, A. L. , Fijnvandraat, K. , & Ljung, R. (2017). Intracranial haemorrhage in children and adolescents with severe haemophilia A or B ‐ the impact of prophylactic treatment. British Journal of Haematology, 179, 298–307. 10.1111/bjh.14844
    1. Blanchette, V. S. , Key, N. S. , Ljung, L. R. , Manco‐Johnson, M. J. , van den Berg, H. M. , & Srivastava, A. (2014). Definitions in hemophilia: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis: JTH, 12(11), 1935–1939. 10.1111/jth.12672
    1. Fischer, K. , Ljung, R. , Platokouki, H. , Liesner, R. , Claeyssens, S. , Smink, E. , & van den Berg, H. M. (2014). Prospective observational cohort studies for studying rare diseases: The European PedNet. Haemophilia Registry. Haemophilia, 20(4), e280–e286. 10.1111/hae.12448
    1. Gomez, K. , & Chitlur, M. (2013). Survey of laboratory tests used in the diagnosis and evaluation of haemophilia A. Thrombosis and Haemostasis, 109(4), 738–743. 10.1160/th12-02-0108
    1. Gomez, K. , Laffan, M. , Keeney, S. , Sutherland, M. , Curry, N. , & Lunt, P. (2019). Recommendations for the clinical interpretation of genetic variants and presentation of results to patients with inherited bleeding disorders. A UK Haemophilia Centre Doctors' Organisation Good Practice Paper. Haemophilia, 25(1), 116–126. 10.1111/hae.13637
    1. Goodeve, A. C. , & Peake, I. R. (2003). The molecular basis of hemophilia A: Genotype‐phenotype relationships and inhibitor development. Seminars in Thrombosis and Hemostasis, 29(1), 23–30. 10.1055/s-2003-37936
    1. Gouw, S. C. , van den Berg, H. M. , Oldenburg, J. , Astermark, J. , de Groot, P. G. , Margaglione, M. , & van der Bom, J. G. (2012). F8 gene mutation type and inhibitor development in patients with severe hemophilia A: Systematic review and meta‐analysis. Blood, 119(12), 2922–2934. 10.1182/blood-2011-09-379453
    1. Gouw, S. C. , van der Bom, J. G. , Ljung, R. , Escuriola, C. , Cid, A. R. , Claeyssens‐Donadel, S. , & van den Berg, H. M. (2013). Factor VIII products and inhibitor development in severe hemophilia A. New England Journal of Medicine, 368(3), 231–239. 10.1056/NEJMoa1208024
    1. Halldén, C. , Nilsson, D. , Säll, T. , Lind‐Halldén, C. , Lidén, A. C. , & Ljung, R. (2012). Origin of Swedish hemophilia A mutations. Journal of Thrombosis and Haemostasis: JTH, 10(12), 2503–2511. 10.1111/jth.12010
    1. Johnsen, J. M. , Fletcher, S. N. , Huston, H. , Roberge, S. , Martin, B. K. , Kircher, M. , & Konkle, B. A. (2017). Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative. Blood Advances, 1(13), 824–834. 10.1182/bloodadvances.2016002923
    1. Karczewski, K. J. , Francioli, L. C. , Tiao, G. , Cummings, B. B. , Alföldi, J. , Wang, Q. , & Genome Aggregation Database, C. (2020). The mutational constraint spectrum quantified from variation in 141,456 humans. Nature, 581(7809), 434–443. 10.1038/s41586-020-2308-7
    1. Li, T. , Miller, C. H. , Payne, A. B. , & Craig Hooper, W. (2013). The CDC Hemophilia B mutation project mutation list: A new online resource. Molecular Genetics & Genomic Medicine, 1(4), 238–245. 10.1002/mgg3.30
    1. Ljung, R. , Kling, S. , Sjorin, E. , & Nilsson, I. M. (1991). More than half the sporadic cases of hemophilia A in Sweden are due to a recent mutation. Acta Paediatrica Scandinavica, 80(3), 343–348. 10.1111/j.1651-2227.1991.tb11860.x
    1. Ljung, R. , Petrini, P. , & Nilsson, I. M. (1990). Diagnostic symptoms of severe and moderate haemophilia A and B. A survey of 140 cases. Acta Paediatrica Scandinavica, 79(2), 196–200. 10.1111/j.1651-2227.1990.tb11438.x
    1. Mahlangu, J. , Cerquiera, M. , & Srivastava, A. (2018). Emerging therapies for haemophilia—Global perspective. Haemophilia, 24(Suppl 6), 15–21. 10.1111/hae.13510
    1. Manco‐Johnson, M. J. , Abshire, T. C. , Shapiro, A. D. , Riske, B. , Hacker, M. R. , Kilcoyne, R. , & Evatt, B. L. (2007). Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. New England Journal of Medicine, 357(6), 535–544. 10.1056/NEJMoa067659
    1. Mannucci, P. M. , & Tuddenham, E. G. (2001). The hemophilias—From royal genes to gene therapy. New England Journal of Medicine, 344(23), 1773–1779. 10.1056/nejm200106073442307
    1. Martensson, A. , Ivarsson, S. , Letelier, A. , Manderstedt, E. , Hallden, C. , & Ljung, R. (2016). Origin of mutation in sporadic cases of severe haemophilia A in Sweden. Clinical Genetics, 90(1), 63–68. 10.1111/cge.12709
    1. McVey, J. H. , Rallapalli, P. M. , Kemball‐Cook, G. , Hampshire, D. J. , Giansily‐Blaizot, M. , Gomez, K. , & Ludlam, C. A. (2020). The European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor Variant Databases: Important resources for haemostasis clinicians and researchers. Haemophilia, 26(2), 306–313. 10.1111/hae.13947
    1. Niroula, A. , & Vihinen, M. (2016). Variation interpretation predictors: Principles, types, performance, and choice. Human Mutation, 37(6), 579–597. 10.1002/humu.22987
    1. Payne, A. B. , Miller, C. H. , Kelly, F. M. , Michael Soucie, J. , & Craig Hooper, W. (2013). The CDC Hemophilia A Mutation Project (CHAMP) mutation list: A new online resource. Human Mutation, 34(2), E2382–E2391. 10.1002/humu.22247
    1. Richards, S. , Aziz, N. , Bale, S. , Bick, D. , Das, S. , Gastier‐Foster, J. , Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405–424. 10.1038/gim.2015.30
    1. Seary, M. E. , Feldman, D. , & Carcao, M. D. (2012). DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype. Haemophilia, 18(1), 50–55. 10.1111/j.1365-2516.2011.02572.x
    1. Swystun, L. L. , & James, P. D. (2017). Genetic diagnosis in hemophilia and von Willebrand disease. Blood Reviews, 31(1), 47–56. 10.1016/j.blre.2016.08.003
    1. Wallis, Y. , Payne, S. , McAnulty, C. , Bodmer, D. , Sistermans, E. , Robertson, K. , & Devereau, A. (2013). Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics. Association for Clinical Genetic Science and the Dutch Society of Clinical Genetic Laboratory Specialists.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit